We are looking at doing RNAseq on around 36 samples we have extracted and want to outsource the library prep. I have shopped around a little and everything seems to be above $200. Does anyone know of any "economy" services that are a little less expensive. Thanks in advance.
Unconfigured Ad
Collapse
X
-
Hi Myrmex,
We can come close: $220 for 24+ Stranded RNASeq libraries. We still do full QC on the starting RNA and use the Illumina prep kits, along with full QC and qPCR on the final library pool for optimal loading. Are you with University of Illinois Chicago?
-
-
It looks like you can get prep for $223 per sample with 8 or more samples at the University of Texas Genomic Sequencing and Analysis Facility. I have worked with them for over 3 years on various projects as a postdoc at UT and while at Bioo Scientific and they are top-notch.
Also, you may want to consider doing the preps yourself, or finding a lab that would collaborate to do the preps there. If you use a kit from a less expensive company than Illumina (Bioo Scientific, Kapa, NEB, and others), you can prepare your libraries for well under $100 each.
Comment
-
-
Hello, our facility can provide 36 stranded mRNA preps for $196.56 per sample. You can visit our website to review our services and find information to contact core staff directly.
Comment
-
-
If you have a lot of samples (>24), which is in good quality and easy to handle, you can negotiate for some discount, for example, libraries for less than $200. However, if you are handling challenging samples, such as FFPE, degraded, low input, you can hardly get such a price. We usually offer a generous discount for new customers. Check here for our promotional price for RNA Sequencing.
Comment
-
-
You can do a mRNA-seq library prep search on Genohub.com: https://genohub.com/#q=a9ce1f402a. Costs (including QC) start at $165/sample (no sample number minimums).
Each service comes with a quality and turnaround time guarantee
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
33 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
Comment